FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

416588003: Alemtuzumab 30mg/mL infusion concentrate (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2546798016 Alemtuzumab 30mg/mL infusion concentrate (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2549105017 Alemtuzumab 30mg/mL infusion concentrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2553865018 Alemtuzumab 30mg/1mL infusion concentrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3650341000005119 alemtuzumab 30 mg/ml koncentrat til infusionsvæske da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    alemtuzumab 30 mg/ml koncentrat til infusionsvæske Is a Product containing alemtuzumab (medicinal product) false Inferred relationship Some
    alemtuzumab 30 mg/ml koncentrat til infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monoclonal antibody false Inferred relationship Some
    alemtuzumab 30 mg/ml koncentrat til infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Alemtuzumab false Inferred relationship Some
    alemtuzumab 30 mg/ml koncentrat til infusionsvæske Has manufactured dose form injektionsvæske false Inferred relationship Some
    alemtuzumab 30 mg/ml koncentrat til infusionsvæske Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    alemtuzumab 30 mg/ml koncentrat til infusionsvæske Has manufactured dose form koncentrat til infusionsvæske false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start